Use of moclobemide and metabolites for treating and...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/5375 (2006.01) A61K 31/55 (2006.01) A61K 45/06 (2006.01) A61P 25/30 (2006.01) A61P 25/32 (2006.01) A61P 25/36 (2006.01)

Patent

CA 2338326

Methods and compositions for using moclobemide, a moclobemide metabolite, a moclobemide derivative or a moclobemide composition to assist in treating or preventing physical dependence on, or withdrawal symptoms associated with alcohol and drugs, including opioids, other central nervous system depressants such as sedatives, central nervous system stimulants such as cocaine and amphetamines, and other drugs active upon the central nervous system.

La présente invention concerne des procédés et compositions destinés à l'utilisation de moclobémide, d'un métabolite de moclobémide, d'un dérivé de moclobémide ou d'une composition de moclobémide afin de traiter ou de prévenir la dépendance physique, ou les symptômes de sevrage associés à l'alcool et aux drogues, y compris aux opioïdes, aux neurodépresseurs du système nerveux central tels que des sédatifs, aux stimulants du système nerveux central tels que la cocaïne et des amphétamines, et aux autres drogues actives sur le système nerveux central.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of moclobemide and metabolites for treating and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of moclobemide and metabolites for treating and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of moclobemide and metabolites for treating and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1357452

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.